Genital herpes infection: A review

International Journal of Epidemiology

Volumn 26, Issue 4, 1997, Pages 698-709

  Brugha, R ^a   Keersmaekers, K ^b   Renton, A ^c   Meheus, A ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Genital herpes; Herpes simplex virus; HSV 1; HSV 2

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; HERPES VACCINE;

AGE; DISEASE SEVERITY; ETHNIC GROUP; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SOCIAL CLASS; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; DISEASE TRANSMISSION; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INCIDENCE; MALE; PREVALENCE; SEROLOGIC TESTS; SEXUALLY TRANSMITTED DISEASES, VIRAL; VACCINATION; VIRUS SHEDDING;

EID: 0030798381     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/26.4.698     Document Type: Review

References (127)

1. Kinghorn G R. Genital herpes: Natural History and Treatment of Acute Episodes. J Med Virol 1993; (Suppl. 1): 33-38.
2. Corey L. Genital herpes In: Holmes K, Mårdh P-A, Sparling F P, Wiesner P J (eds). Sexually Transmitted Diseases. New York: McGraw Hill Information Services Company, 1990, ch. 35.
3. Mindel A, Adler M W, Sutherland S, Fiddian A P. Intravenous acyclovir treatment for primary genital herpes. Lancet 1982; 697-700.
4. Corey L, Fife K H, Benedetti J K et al. Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med 1983; 98: 958-72.
5. Mertz G J, Critchlow C J, Benedetti J et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984; 252: 1147-51.
6. Nilsen A E, Assen T, Halsos A M et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982; ii: 571-73.
7. Bryson Y, Dillon M, Lovett M et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomised double-blind controlled trial in normal subjects. N Engl J Med 1983; 3308: 916-21.
8. Spear P G. Biology of the herpesviruses. In: Holmes K, Mårdh P-A, Sparling F P, Wiesner P J (eds). Sexually Transmitted Diseases, New York: McGraw Hill Information Services Company, 1990, ch. 34.
9. Stewart J A, Reef S E, Pellet P E, Corey L, Whitley R J, Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21 (Suppl. 1): S114-20.
10. Chang Y, Cesarman E, Pessin M S et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-68.
11. Nathwani D, Wood M J, Herpesvirus infections in childhood: 1. Br J Hosp Med 1993; 50: 233-41.
12. Mertz G J. Epidemiology of genital herpes infections. Infect Dis Clin N Am 1993; 7: 825-39.
13. Corey L. The current trend in genital herpes; Progress in prevention. Sex Transm Dis 1994; 21 (Suppl.): S38-S44.
14. Corey L, Adams H G, Brown Z A, Holmes K K. Genital herpes simplex virus infections: clinical manifestations, course and complications. Ann Intern Med 1983; 98: 958-72.
15. Kinghorn G R. Epidemiology of genital herpes. J Int Med Res 1994; 22 (Suppl. 1): 14A-23A.
16. Lee F K, Coleman R M, Pereira L, Bailey P D, Tatsuno M, Nahmias A J. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 1985; 22: 641-44.
17. Lee F K, Pereira L, Griffen C, Reid E, Nahmias A J. A novel glycoprotein for detection of herpes simplex virus type 1 specific antibodies. J Virol Methods 1986; 14: 111-18.
18. Ashley R L. Laboratory techniques in the diagnosis of herpes simplex infection. Cenitourin Med 1993; 69: 174-83,
19. Mertz G J, Schmidt O, Jourden J L et al. Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985; 12: 33-39.
20. Corey L. First-episode, recurrent, and asymptomatic herpes simplex infections. J Am Acad Dermatol 1988; 18: 169-72.
21. Sasadeusz J J, Sucks S L. Herpes latency, meningitis, radiculomyelopaihy and disseminated infection. Genitourin Med 1994; 70: 369-77.
22. Sexually transmitted diseases quarterly report: genital warts and genital herpes simplex virus infections in England and Wales: 1994. CDR Weekly. 1995; 5: 186-88.
23. Benedetti J, Corey L, Ashley R, Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Int Med 1994; 121: 847-54.
24. Lafferty W E, Coombs R W, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection: influence of anatomic site and viral type. N Engl J Med 1987; 316: 1444-49.
25. Breinig M K, Kingsley L A, Armstrong J A, Freeman D J, Ho M. Epidemiology of genital herpes in Pittsburgh: Serologic. sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990; 162: 299-305.
26. Gibson J J, Hornung C A, Alexandra G R, Lee F K, Potts W A, Nahmias A J. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Occurrence and determinants of infection. J Infect Dis 1990; 162: 306-12.
27. Stavraky K M, Rawls W E, Chiavetta J, Donner A P, Wanklin J M. Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2. Am J Epidemiol 1983; 118: 109-21.
28. Koutsky L A, Stevens C E, Holmes K K et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. New Engl J Med 1992; 326: 1533-39.
29. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having 'asymptomatic' herpes simplex virus type 2 infection. Ann Intern Med 1989; 110: 882-87.
30. Whitley J. Herpes simplex virus infections of women and their offspring: Implications for a developed society. Proc Natl Acad Sci USA 1994; 91: 2441-47.
31. Luby E D, Klinge V. Genital herpes: a pervasive psychosocial disorder. Arch Dermatol 1985; 121: 494-97.
32. Van der Plate C, Aral S O. Psychological aspects of genital herpes virus infection. Health Psychol 1987; 6: 57-72.
33. Carney O, Ross E, Bunker C, Ikkos G, Mindel A. A prospective study of the psychological impact on patients with a first-episode of genital herpes. Genitourin Med 1994; 70: 40-45.
34. Goldmeier D, Johnson A, Byrne M, Barton S. Psychosocial implications of recurrent genital herpes simplex virus infection. Genitourin Med 1988; 64: 327-30.
35. Fenemma J S A, van Ameijden E J C, Coutinho R A, van den Hoek AJAR. HIV. sexually transmitted diseuses and gynaecologic disorders in women: increased risk for genital herpes and wurts among HIV-infected prostitutes in Amsterdam. AIDS 1995; 9: 1071-78.
36. Bagdades E, Pillay D, Squire S et al. Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS 1992; 6: 1317.
37. Centers for Disease Control: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: 15.
38. Augenbraun M H, Feldman J, Chirgwin K et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995; 123: 845-47.
39. Kreis J, Caraël M, Meheus A. Rôle of sexually transmitted diseases in transmitting human immunodeficiency virus. Genitourin Med 1988; 64: 1-2.
40. Stamm W E, Handsfield H H, Rompalo A M, Ashley R L, Roberts P L, Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260: 1429-33.
41. Holmberg S B, Stewart J A, Geger A R et al. Prior HSV type 2 infection as a risk factor for HIV infection. JAMA 1988; 259: 1048-51.
42. Hook E W, Cannon R O, Nahmias A J et al. Herpes simplex virus infection as a risk factor Cor human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992; 165: 251-55.
43. Corey L. Herpes simplex virus infections during the decade since the licensure of acyclovir. J Med Virol 1993; (Suppl. 1): 7-12.
44. O'Farrell N, Tovey S J. High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London. Int J STD AIDS 1995; 5: 415-18.
45. Kamya M R, Nsubuga P, Grant R M, Hellman N. The high prevalence of genital herpes among patients with genital ulcer disease in Uganda. Sex Transm Dis 1995; 22: 351-54.
46. Golden M P, Kim S, Hammer S M et al. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992; 166: 494-99.
47. Heng M C Y, Siang Y H, Allen S G. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1994; 343: 255-58.
48. Bryson Y, Dillon M, Bernstein D I, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: A prospective couple study. J Infect Dis 1993; 167: 942-46.
49. Koelle D M, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Int Med 1992; 116: 433-37.
50. Wald A, Zeh J, Selke S, Ashley R L, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 33: 770-75.
51. Burton S E, Munday P E, Patel R J. Asymptomatic shedding of herpes simplex virus from the genital tract: uncertainty and its consequences for patient management. Int J STD AIDS 1996; 7: 229-32.
52. Johnson R E, Nahmias A J, Magder L S, Lee F K, Brooks C A, Snowden C B. A seroepidemiological survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321: 7-12.
53. Koutsky L A, Ashley R L, Holmes K K et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Sex Transm Dis 1990; 17: 90-94.
54. England J A, Zimmerman M E, Swierkosz E V, Goodman J L, Scholl D R, Balfour H H. Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Ann Intern Med 1990; 112: 416-22.
55. Kulhanjian J A, Soroush V, Au D S et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992; 326: 916-20.
56. 56i Yeuger A S, Arvin A M. Reasons for the absence of u history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984; 73: 188-96.
57. Brown Z A, Benedetti J, Ashley R et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labour. N Engl J Med 1991; 324: 1247-52.
58. Ashley R, Cent A, Maggs V, Nahmias A J, Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med 1991; 115: 520-26.
59. Mertz G J, Benedetti J, Ashley R, Selke S A, Corey L Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197-202.
60. 6(1 Mertz G J, Coombs R W, Ashley R et al. Unrecognised transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988; 157: 1169-77.
61. Straus S E, Seidlin M, Takiff H E et al. Effect of oral acyclovir treatment on symptomatic and asymptomatic viral shedding in recurrent genital herpes. Sex Transm Dis 1989; 16: 107-13.
62. Wald A, Zeh J, Barnum G, Davis L G, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Int Med 1996; 124: 8-15.
63. Whitley R J. Neonatal herpes simplex virus infections. J Med Virol 1993; (Suppl.): 13-21.
64. Prober C G, Bullender W M, Yasukawa L L, Au D S, Yeager A S, Arvin A M, Low risk of herpes simplex virus infections in neonaies exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987; 316: 240-44.
65. Whitley R J, Nahmias A J, Visintine A M. Fleaning C L, Alford C A, The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66: 489-94.
66. Arvin A M. Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection. Rev Inf Dis 1991; 13 (Suppl. 11): S953-56.
67. Frenkel L M, Garratty E M, Shen J P, Wheeler N, Clark O, Bryson Y J. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993; 118: 414-18.
68. Oliver L, Wald A, Kim M et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med 1995; 4: 228-32.
69. Brown Z A, Benedetti J K, Watts D H er al. A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy. Am J Obstet Cynecol 1995; 172: 1299-303.
70. Field P R, Ho D W T, Cunningham A L. The diagnosis of recent herpes simplex type 2 genital infections by the Simplex-2 test. Pathology 1992; 24: 302-06.
71. Ashley R L, Dalessio J, Dragavon J et al. Under estimation of HSV-2 seroprevalence in a high-risk population by microneutralization assay. Sex Transm Dis 1993; 20: 230-35.
72. Ashley R L, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western Blot (Immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26: 662-67.
73. Slomka M J, Ashley R L, Cowan F M, Cross A, Brown D W G. Monoclonal antibody blocking tests for the detection of HSV 1 and HSV 2 specific humoral responses: comparison with Western blot assay. J Virol Methods 1995; 55: 27-35.
74. Mindel A. Long-term clinical and psychological management of genital herpes. J Med Virol 1993; (Suppl. 1): 39-44.
75. Darby G. Acyclovir-and beyond. J Int Med Res 1994; 22 (Suppl. 1): 33A-42A.
76. Patel R, Barton S E. Antiviral chemotherapy in genital herpes simplex virus infections. Int J STD AIDS 1995; 6: 320-28.
77. Mindel A, Weller I V, Faherty A, Sutherland S, Fiddian A P, Adler M W. Acyclovir in first attacks of genital herpes and prevention of recurrences. Genitourin Med 1986; 62: 28-32.
78. Reichman R C, Badger G J, Mertz G J et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. JAMA 1984; 251: 2103-07.
79. Salo O, Lassus A, Hovi T. Double-blind placebo-controlled trial of oral acyclovir in recurrent genital herpes. Eur J Sex Transm Dis 1983; 1: 95-98.
80. Goldberg L, Kaufman R, Conant M A et al. Oral Acyclovir for episodic treatment of recurrent genital herpes. J Am Acad Dermatol 1986; 15: 256-64.
81. Baker D A. Long-term suppressive therapy with acyclovir for recurrent genital herpes. J Int Med Res 1994; 22 (Suppl. 1): 24A-32A.
82. Collins P, Nixon Ellis M. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol 1993; (Suppl. 1): 58-66.
83. McGrath B J, Newman C L. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome. Pharmacotherapy 1994; 14: 529-42.
84. Easterbrook P, Wood M J. Successors to acyclovir. J Antimicrobial Chemotherapy 1994; 34: 307-11.
85. Minkovitz F B, Pepose J S. Topical interferon alpha-2a treatment of herpes simplex keratitis resistant to multiple antiviral medications in an immunosuppressed patient. Cornea 1995; 14: 326-30.
86. Gibbs R S, Mead P B. Preventing neonatal herpes current strategics. N Engt J Med 1992; 326: 946-47.
87. Jenkins M, Kohl S. New aspects of neonatal herpes. Pediatric Infections 1992; 6: 59-74.
88. Drummond M, Backhouse M. Assessing the economic benefits of antiherpes therapy. J Med Virol 1993; (Suppl. 1): 51-57.
89. Welsby P D. Acyclovir: Is the honeymoon coming to an end? J Infect 1994; 28: 121-29.
90. Chuang T Y, Daniel W P, Perry H O, Ilstrup D M, Kurland L T, Incidence and trend of herpes progenitalis: A 15-year population study. Mayo Clin Proc 1983; 58: 436-41.
91. Guinan M E, Wolinsky S M, Reichman R C. Epidemiology of genital herpes simplex virus infection. Epidemiol Rev 1985; 7: 127-46.
92. Statistical Bulletin. Sexually Transmitted Diseases, England 1994. Government Statistical Service 1995/16.
93. Johnson R E, Lee F, Hadgu A et al. US genital herpes trends during the first decade of AIDS: Prevalences increased in young whites and elevated in blacks. Sex Transm Dis 1994; 21 (Suppl. 2): S109. (Abstract)
94. Jeffries D J. Intra-uterine and neonatal herpes simplex virus infection. Scand J Infect 1991; (Suppl. 78): 21-26.
95. Siegel D, Golden E, Washington A E et al. Prevalence and correlates of herpes simplex infections: the populationbased AIDS in Multiethnic Neighborhoods Study. JAMA 1992; 268: 1702-08.
96. Bernstein D I. Effects of prior HSV-1 infection on genital HSV-2 infection. Prog Med Virol Basel: Karger 1991; 38: 109-27.
97. Löwhagen G-B, Jansen E, Nordenfeit E, Lycke E, Epidemiology of genital herpes infections in Sweden. Acta Derm Venereol (StoM) 1990; 70: 330-34.
98. Tardieu J C, Friedel J. Incidence of herpes simplex virus types 1 and 2 in herpes genitalis in Strasbourg. France. Br J Vener Dis 1983; 59: 138
99. Smetana H, Dulitzky M, Movshovitz M, Isacsohn M, Seidman A N, Levenion-Knss S. Selected epidemiological features of herpes genilalis in Israel based on laboratory data. Isr J Med Sci 1994; 30: 375-79.
100. Nahmias A J, Lee F K, Beckman-Nuhmias S. Seroepidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; (Suppl. 69): 19-36.
101. Cowan F M, Johnson A M, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. Br Med J 1994; 309: 1325-29.
102. Ades A E, Peckham C S, Dale G E, Best J M, Jeansson S, Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989; 43: 53-60.
103. Christenson B, Bottiger M, Svensson A, Jeansson S. A 15-year surveillance study of antibodies to herpes simplex virus type 1 and 2 in a cohort of young girls. J Infect Dis 1992; 25: 147-54.
104. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994; 5: 113-16.
105. Persson K, Månsson A, Jönsson E, Nordenfeit R. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993, indicated by a similar change in antibody pattern. Scand J Infect Dis 1995; 27: 195-99.
106. Hildesheim A, Mann V, Brinton L A, Szklo M, Reeves W C, Rawls W E. Herpes simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer 1991; 49: 335-40.
107. Adimora A A, Sparling F, Cohen M S. Vaccines for classic sexually transmitted diseases. Infect Dis Clin N Am 1994; 8: 859-76.
108. Rodgers C A, O'Mahony C. High prevalence of herpes simplest virus type 1 in female anogenital herpes simplex. Int J STD AIDS 1995; 6: 144. (Letter)
109. Randolph A G, Washington E, Prober C G. Cesareun delivery for women presenting with genital herpes lesions. JAMA 1993; 270: 77-82.
110. Binkin N J, Jeffrey P, Koplan P, The high cost and low efficacy of weekly viral cultures for pregnant women and recurrent genital herpes: A reappraisal. Medical Decision Making 1989; 9: 225-30.
111. Cone R W, Hobson A C, Brown Z et al. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women, JAMA 1994; 272: 792-96.
112. Bos C A. Hypothetical vaccination of the Dutch population with a herpes simplex virus vaccination; estimation of the profitability using a demographic projection model. Vaccine 1988; 6: 309-13.
113. Burke R L. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Rev Infect Dis 1991; 13: S906-11.
114. Burke R L, Goldbeck C, Ng P, Stanberry L, Ott G, Van Nest G. The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine. Rev Infect Dis 1994; 170: 1110-19.
115. Langenberg A G M, Burke R L, Adair S F et al. A recombinant glycoprotein vaccine for herpes simplex type 2: Safety and efficacy. Ann Intern Med 1995; 122: 889-98.
116. Dundarov S, Andonov P. Seventeen years of application of herpes vaccines in Bulgaria. Acta Virologica 1994; 38: 205-08.
117. Straus S E, Corey L, Burke R L er al. Placebo-controlled trial of vaccination with recombinant glyeoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes, Lancet 1994; 343: 1460-63.
118. Cohen J. Vaccines get a new twist. Science 1994; 264: 503-05.
119. Secular A, Leask BGS, Carrington D. Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow 1985-1988. Genitourin Med 1990; 66: 226.
120. Ross J D C, Smith I W, Elton R A. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993; 69: 381-83.
121. Tayal S C, Pattman R S. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. Int J STD AIDS 1994; 5: 359-61.
122. Smith I W, Peutherer J F, Robertson D H H. Virological studies in genital herpes. Lancet 1976; 11: 1089.
123. Barton I G, Kinghorn G R, Najem S, Al-Omar L S, Porter C W. incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis 1982; 58: 44-47.
124. l24 Lavery H A, Connolly J H, Russell J D. Incidence of herpes genitalis in Northern Ireland in 1973-83 and herpes simplex types 1 and 2 isolated in 1982-4. Genitourin Med 1986; 62: 24-27.
125. Woolley P D, Kudesia G. Incidence of herpes simplex virus type-1 and type-2 from patients with primary (first-attack) genital herpes in Sheffield. Int J STD AIDS 1990; 1: 184-86.
126. Wilson P, Cropper L, Sharp I, Fink C. Apparent increase in the prevalence of herpes simplex virus type 1 genital infections among women. Genitourin Med 1994; 70: 228.
127. Edwards S, White C, Genital herpes simplex virus type 1 in women. Genitourin Med 1994; 70: 426.